Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Reexamination Certificate
2004-06-29
2009-08-25
Desai, Anand U (Department: 1656)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
C514S002600, C530S300000
Reexamination Certificate
active
07579013
ABSTRACT:
The invention provides for a formulation for coating one or more microprojections which reduces or minimizes the loss of counterions from the coating in order to achieve a pH-stabilized formulation.
REFERENCES:
patent: 2619962 (1952-12-01), Rosenthal
patent: 2893392 (1959-07-01), Wagner et al.
patent: 3072122 (1963-01-01), Rosenthal
patent: 3123212 (1964-03-01), Taylor et al.
patent: 3136314 (1964-06-01), Kravitz
patent: RE25637 (1964-09-01), Kravitz et al.
patent: 3221739 (1965-12-01), Rosenthal
patent: 3221740 (1965-12-01), Rosenthal
patent: 3678150 (1972-07-01), Szumski et al.
patent: 3814097 (1974-06-01), Ganderton et al.
patent: 3964482 (1976-06-01), Gerstel et al.
patent: 4109655 (1978-08-01), Chacornac
patent: 4453926 (1984-06-01), Galy
patent: 4714621 (1987-12-01), Gullberg et al.
patent: 5066494 (1991-11-01), Becher
patent: 5250023 (1993-10-01), Lee et al.
patent: 5279544 (1994-01-01), Gross et al.
patent: 5487726 (1996-01-01), Rabenau et al.
patent: 5738728 (1998-04-01), Tisone
patent: 5741554 (1998-04-01), Tisone
patent: 5743960 (1998-04-01), Tisone
patent: 5770220 (1998-06-01), Meconi et al.
patent: 5866536 (1999-02-01), Leone-Bay et al.
patent: 5879326 (1999-03-01), Godshell et al.
patent: 5916524 (1999-06-01), Tisone
patent: 5983136 (1999-11-01), Kamen
patent: 6050988 (2000-04-01), Zuck
patent: 6083196 (2000-07-01), Trautman et al.
patent: 6091975 (2000-07-01), Daddona et al.
patent: 6230051 (2001-05-01), Cormier et al.
patent: 6322808 (2001-11-01), Trautman et al.
patent: 6331310 (2001-12-01), Roser et al.
patent: 6379324 (2002-04-01), Gartstein et al.
patent: 6440096 (2002-08-01), Lastovich et al.
patent: 6454755 (2002-09-01), Godshall
patent: 6537242 (2003-03-01), Palmer
patent: 6565532 (2003-05-01), Yuzhakov et al.
patent: 6589202 (2003-07-01), Powell
patent: 6652478 (2003-11-01), Gartstein et al.
patent: 6689100 (2004-02-01), Connelly et al.
patent: 6743211 (2004-06-01), Prausnitz et al.
patent: 6811792 (2004-11-01), Roser et al.
patent: 6835184 (2004-12-01), Sage et al.
patent: 6855131 (2005-02-01), Trautman et al.
patent: 6855372 (2005-02-01), Trautman et al.
patent: 6881203 (2005-04-01), Delmore
patent: 6884427 (2005-04-01), Barrows
patent: 6918901 (2005-07-01), Theeuwes et al.
patent: 6931277 (2005-08-01), Yuzhakov et al.
patent: 6953589 (2005-10-01), Trautman et al.
patent: 7097631 (2006-08-01), Trautman et al.
patent: 7131960 (2006-11-01), Trautman et al.
patent: 7184826 (2007-02-01), Cormier et al.
patent: 2002/0082543 (2002-06-01), Park et al.
patent: 2002/0087182 (2002-07-01), Trautman et al.
patent: 2002/0128599 (2002-09-01), Cormier et al.
patent: 2002/0132054 (2002-09-01), Trautman et al.
patent: 2002/0177839 (2002-11-01), Cormier et al.
patent: 2002/0193729 (2002-12-01), Cormier et al.
patent: 2003/0100885 (2003-05-01), Pettis et al.
patent: 2003/0135201 (2003-07-01), Gonnelli
patent: 2003/0181936 (2003-09-01), Trautman et al.
patent: 2003/0199810 (2003-10-01), Trautman et al.
patent: 2003/0199811 (2003-10-01), Sage, Jr. et al.
patent: 2004/0062813 (2004-04-01), Cormier et al.
patent: 2004/0138610 (2004-07-01), Cormier et al.
patent: 2004/0236271 (2004-11-01), Theeuwes et al.
patent: 2005/0008683 (2005-01-01), Mikszta et al.
patent: 2005/0084604 (2005-04-01), Trautman et al.
patent: 2005/0106209 (2005-05-01), Ameri et al.
patent: 2005/0123507 (2005-06-01), Ameri
patent: 2005/0148926 (2005-07-01), Trautman et al.
patent: 2006/0047243 (2006-03-01), Rosenberg
patent: 2006/0074377 (2006-04-01), Cormier et al.
patent: 2006/0188555 (2006-08-01), Cormier et al.
patent: 0407063 (1990-06-01), None
patent: 1110455 (2001-06-01), None
patent: 1283043 (2003-02-01), None
patent: 1 358 896 (2003-11-01), None
patent: 1 517 722 (2005-03-01), None
patent: 0017999.4 (1922-05-01), None
patent: 878788 (1961-10-01), None
patent: 96/03978 (1996-02-01), None
patent: 96/10630 (1996-04-01), None
patent: WO 96/17648 (1996-06-01), None
patent: WO 96/37155 (1996-11-01), None
patent: WO 96/37256 (1996-11-01), None
patent: WO 97/03718 (1997-02-01), None
patent: WO 97/48442 (1997-06-01), None
patent: 97/48440 (1997-12-01), None
patent: WO 97/48440 (1997-12-01), None
patent: WO 97/48441 (1997-12-01), None
patent: WO 98/00193 (1998-01-01), None
patent: WO 98/11937 (1998-03-01), None
patent: 98/28037 (1998-07-01), None
patent: WO 98/28037 (1998-07-01), None
patent: WO 98/29298 (1998-07-01), None
patent: WO 98/29365 (1998-07-01), None
patent: WO 99/38492 (1999-08-01), None
patent: 99/64580 (1999-12-01), None
patent: WO 99/64580 (1999-12-01), None
patent: 00/12173 (2000-03-01), None
patent: WO 00/21533 (2000-04-01), None
patent: 00/35530 (2000-06-01), None
patent: WO 00/37079 (2000-06-01), None
patent: WO 00/43405 (2000-07-01), None
patent: 00/44438 (2000-08-01), None
patent: WO 01/41863 (2001-06-01), None
patent: 02/07813 (2002-01-01), None
patent: WO 02/00200 (2002-01-01), None
patent: WO 02/07813 (2002-01-01), None
patent: 02/074173 (2002-09-01), None
patent: WO 02/085447 (2002-10-01), None
patent: WO 02/094368 (2002-11-01), None
patent: 1 301 238 (2003-04-01), None
patent: WO 03/051284 (2003-06-01), None
patent: WO 2005/002453 (2005-01-01), None
patent: WO 2005/004729 (2005-01-01), None
Suzuki et al. Journal of Pharmaceutical Sciences 91(2): 350-361 (2002). “Prevention of Bone Loss in Ovariectomized Rats by Pulsatile Transdermal lontophorectic Administration of Human PTH(1-34)”.
Edsall J.T., Proteins as Acids and Bases, 20:444-505, (1943).
International Search Report dated Mar. 2, 2005 for corresponding Appn. PCT/US2004/021004.
Gorukanti, et al. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation. Int J Pharm. 1999; 192(2):159-72.
Hatanaka, et al. Ion pair skin transport of a zwitterionic drug, cephalexin. J Control Release. 2000; 66(1):63-71.
Valenta, et al. The dermal delivery of lignocaine: influence of ion pairing. Int J Pharm. 2000; 197(1-2):77-85.
Gribbon, et al., “Stabilisation of Vaccines Using trehalose (Q-T4) Technology”, Brown F(ed); New Approaches to Stabilation of Vaccines Potency, Dev Biol Stand. Basel, Karger, 1996; vol. 87; pp. 193-199.
Franks, “Solid aqueous solutions”; Pure & Appl. Chem.; vol. 65; No. 12; 1993; pp. 2527-2537.
Coleco et al.; Research/“Extraordinary Stability of Enzymes Dried in Trehalose: Simplified Molecular Biology”; bio/Technology; vol. 10; Sep. 1992; pp. 1007-1011.
“Report of the Technical Review Group Meeting”; WHO, Jun. 7-8, 1999; pp. 1-88.
“A plethora of hi-tech vaccines-genetic, edible, sugar glass, and more”; Children's Vaccine Initiative; CVI Forum 18; 1999; pp. 1-24.
“Report on the first meeting of the steering committee on Immunization Safety”; WHO Geneva; Oct. 25-26, 1999; pp. 1-44.
Roberts, et al.; “Solute Structure as a Determinant of lontophoretic Transport”; Mechanisms of Transdermal Drug Delivery; R. O. Potts and R. H. Guy (Ed); Marcel Dekker (1997); pp. 291-349.
Chang, et al.; “Use of Subambient Thermal Analysis to Optimize Protein Lyophilization”; Cryobiology 29; (1992); pp. 632-656.
Wang, “Lyophilzation and development of solid protein pharmaceuticals”; International Journal of Pharmaceutics; 203; (2000); pp. 1-60.
Carpenter, et al.; “Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice”; Pharmaceutical Research; vol. 14; No. 8; 1997; pp. 969-975.
Huang, et al.; “Microencapsulation for Gene Delivery”; Encyclopedia of Controlled Drug Delivery; John Wiley & Sons, Inc.; (1999); pp. 546-553.
General Policy Issues, “Wider access to HIV drugs now a reality”; WHO Drug Information; vol. 12; No. 2; 1998; pp. 67-99.
Roos; “Melting and glass transitions of low molecular weight carbohydrates”; Carbohydrate Research; 238; (1993); pp. 39-48.
Schunk et al.; “Liquid film coating”; Scientific principles and their technological implications; Kistler and Schweizer; Editors; Chapan & Hall; London; (1997); pp. 673-708.
“HIV/PPD Conjugate
Ameri Mahmoud
Cormier Michel J. N.
Lin Wei-Qi
Maa Yuh-Fun
Alza Corporation
Desai Anand U
Edwards Angell Palmer & & Dodge LLP
Williams Kathleen
LandOfFree
Formulations for coated microprojections containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulations for coated microprojections containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations for coated microprojections containing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4097445